JD Supra3h
FDA in focus: 2024 in review and 2025 outlook
In 2024, the Food and Drug Administration (FDA) significantly invested in reorganizing its internal infrastructure and enhancing operations.
BioPharma Dive2h
Following FDA cuts, Trump nominee Makary vows ‘independent’ staff review
The Johns Hopkins surgeon highlighted rapid growth at the agency, but pledged key staff will have “all the resources they ...
Makary tells Senate panel he plans to review FDA job cuts
FDA nominee Martin Makary was asked about abortion drugs, vaccine panels during a Senate hearing on his bid to lead the ...
‘We Were Told Nothing.’ What to Know About the Canceled Meeting to Discuss the Next Flu Shot
The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest ...
Reuters12d
US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink
Americans need “an efficient, effective FDA review process that helps advance ... Retail & Consumercategory South Africa's RCL Foods reports 38.8% rise in half-year earnings 5:50 AM UTC ...
MedTech Dive10d
FDA brings back some fired device staff
An industry source said “most, if not all” of the people at the CDRH who were recently dismissed are now being asked to ...
FDA Moves to Rehire Medical Device, Food Safety and Other Staffers Fired Days Earlier
The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, ...
BioPharma Dive5h
Makary, under review to run FDA, evades pressure to reinstate canceled vaccine meeting
Questioned by senators at a Thursday hearing, President Trump's FDA nominee said he would reevaluate which scientific topics require an advisory committee's input.